The EC Innovative Medicine Initiatives (IMI) website highlights two publications of the ULB Center for Diabetes Research, developed in the context of the IMI project INNODIA and showing evidence of genetic regulation of the cross talk between the target tissues and the immune system in T1D and other autoimmune diseases.